Cyclin-dependent kinase inhibitors (CDKIs) and the DNA damage response: The link between signaling pathways and

Jafar Amani1, Nassim Gorjizadeh2, Simin Younesi3

  • 1Applied Microbiology Research Center, System Biology and Poisonings Institute, Baqiyatallah University of Medical Sciences, Tehran, Iran.

DNA Repair
|April 3, 2021
PubMed

Insights

DNA repair is vital for genomic stability, and its disruption contributes to cancer. Understanding cyclin-dependent kinase inhibitors (CDKIs) in DNA damage response may lead to new cancer treatments.

Area of Science:

  • Molecular Biology
  • Cell Biology
  • Cancer Research

Background:

  • Genomic integrity and stability are maintained by DNA repair mechanisms at the cellular level.
  • DNA damage is a key factor in the initiation and progression of tumors.
  • Cyclin-dependent kinases (CDKs) regulate cell cycle progression, and their aberrant activity is linked to various cancers.

Purpose of the Study:

  • To explore the role of cyclin-dependent kinase inhibitors (CDKIs) in the DNA damage response.
  • To understand how CDKIs regulate multiple signaling pathways involved in DNA damage.
  • To identify potential therapeutic strategies for cancer treatment by targeting CDKIs.

Main Methods:

  • The study reviews existing literature on DNA repair, cell cycle regulation, and CDKIs.
  • It analyzes the involvement of INK4 and Cip/Kip families of CDKIs in cellular processes.
  • The focus is on understanding signaling pathways connecting CDKIs to DNA damage response.

Main Results:

  • Disruptions in cell cycle regulators, including CDKIs, lead to uncontrolled cell proliferation.
  • CDKIs play roles in cell cycle regulation, transcription, apoptosis, and cell migration.
  • Understanding CDKI involvement in DNA damage response is crucial for cancer biology.

Conclusions:

  • Targeting CDKIs offers a potential strategy for developing novel cancer treatments.
  • Further research into CDKI-mediated signaling pathways can enhance therapeutic interventions.
  • Elucidating the role of CDKIs in DNA damage response is key to inhibiting carcinogenesis.

Related Concept Videos

DNA Damage can Stall the Cell Cycle02:37

DNA Damage can Stall the Cell Cycle

In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...
9.7K
DNA Damage Can Stall the Cell Cycle02:37

DNA Damage Can Stall the Cell Cycle

2.8K
M-Cdk Drives Transition Into Mitosis02:15

M-Cdk Drives Transition Into Mitosis

Checkpoints throughout the cell cycle serve as safeguards and gatekeepers, allowing the cell cycle to progress in favorable conditions and slow or halt it in problematic ones. This regulation is known as the cell cycle control system.
Cyclin-dependent kinases, or Cdks, work in concert with cyclins to control cell cycle transitions. M-Cdk, a complex of Cdk1 bound to M cyclin, is a well-known example of this coordinated control that drives the transition from the G2 to the M phase.
M cyclin...
5.9K
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
6.8K
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
5.2K